Wilson's Disease: A Review for the General Pediatrician

Pediatr Ann. 2018 Nov 1;47(11):e440-e444. doi: 10.3928/19382359-20181026-01.

Abstract

Wilson's disease, also known as hepatolenticular degeneration, is an autosomal recessive genetic disorder due to a mutation of the ATP7B gene resulting in impaired hepatic copper excretion and copper accumulation in various tissues. It is associated with the classic triad of cirrhosis, neurological manifestations, and the ocular finding of Kayser-Fleischer rings; however, the clinical presentation can vary greatly from incidental findings of abnormal liver enzymes to acute liver failure necessitating liver transplant. Pediatric patients may present with subtle findings including asymptomatic hepatomegaly, transaminitis, changes in behavior, movement disorders, or school failure. The general pediatrician may be the first to recognize these symptoms and should consider Wilson's disease in their differential diagnosis. Wilson's disease can be managed with lifelong chelation or zinc therapy in patients who present early in the disease; therefore, pediatricians should have a low threshold for referral to a pediatric hepatologist for further evaluation when it is suspected. [Pediatr Ann. 2018;47(11):e440-e444.].

Publication types

  • Review

MeSH terms

  • Chelating Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Copper / metabolism
  • Hepatolenticular Degeneration / diagnosis*
  • Hepatolenticular Degeneration / drug therapy
  • Humans
  • Pediatricians
  • Penicillamine / therapeutic use*
  • Zinc / therapeutic use*

Substances

  • Chelating Agents
  • Copper
  • Penicillamine
  • Zinc